🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Interesting ETH Zürich initiative - fellowships for medical doctors to do research within a host lab at ETH. Building bridges between ETH and medical research. ethz.ch/en/research/in…

Neue Erkenntnisse zu personalisierten Behandlungsansätzen für Brustkrebspatientinnen. usz.ch/neue-erkenntni…

Unser Jahr im Rückblick: usz.ch/cccz-jahresrue… Ganz herzlichen Dank allen Beteiligten🔝. 2024 kann kommen.

Good CAF or bad CAF, that's the question! In our new paper Cancer Cell we use #imagingmasscytometry to unravel the prognostic effect of cancer-associated #fibroblast (CAF) heterogeneity&their effect on therapy in 1000+ Unispital_USZ lung cancer patients cell.com/cancer-cell/fu…

Online Now: Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer dlvr.it/T1bxBL

We embraced a new kind of precision last weekend, swapping quadrupoles for ski poles! Here's to a great day in snowy Engelberg!

In this Review, de Souza, Zhao & Bodenmiller (Bodenmiller lab) discuss how advances in the high-plex imaging of protein markers at the single-cell & subcellular level has expanded our understanding of #tumourbiology & clincial outcomes. Read it here: go.nature.com/48aPV9p pic.x.com/lnMGxbjMJ3

Welcome Simon Haefliger, our new PhD student! Simon is a MD and previously worked at UniSpitalBaselCH. He will work on a rare #sarcoma called #ClearCellSarcoma. Great to have you in our lab! Have a good start Department of Quantitative Biomedicine

It’s been two months since we joined #ESMOIO2023! We proudly presented the latest IMMUcan #cancerresearch. But what exactly did we bring to the table during those days in early December 2023? Let’s look back! This week, we highlight Daniel Schulz and team!

What's the future of cancer treatment? It’s here... Hear how the Bodenmiller lab is using Imaging Mass Cytometry™ to provide personalized treatment recommendations based on molecular data while improving overall response rates and patient outcomes:  go.standardbio.com/l/838373/2024-…

After months of dedicated training, Bodenmiller lab is thrilled to stand at the start line of #SOLA2024 relay race this Saturday. 113 kilometers, 14 BB Lab members, 1 goal. Come and cheer us on as we’re giving our everything to finish among top 100 fastest teams!

Opportunities and challenges of #precisiononcology: Andreas Wicki and Bernd discuss the power of technology, cost effectiveness, and regulations in the latest #StrategyandInsider podcast episode. Find out how technology and data help in fighting #cancer: podcasts.apple.com/de/podcast/str…

Very excited to have presented our work during the 2024 Nobel Symposia “Spatial Biology In The Genomics Era” at the Science Academy in Stockholm alongside leaders in the field of #spatialbiology and #precisionmedicine.

Congratulations: Dr. Lena Cords receives the German Study Prize by the Körber Foundation!👏 Her research on cancer-associated #fibroblasts offers new options for #cancer #therapy. 👉 t1p.de/5go0s📝 In Detail: 🌟Dr. Lena Cords developed a new classification system

Our review on Highly Multiplexed Tissue Imaging in Precision Oncology is now live in Cancer Discovery! We discuss imaging modalities, their clinical pros/cons, and paths for implementation.Cancer Discovery #Spatialomics aacrjournals.org/cancerdiscover…

It's wonderful to see that spatial proteomics has been recognized as Nature Methods' Method of the Year 2024. nature.com/articles/s4159…

For those interested in the evolution and possible future directions of imaging-based spatial proteomics, I recommend reading our perspective article. nature.com/articles/s4159…

I also highly recommend reading the amazing Method of the Year 2024 perspectives @NatureMethods from Rong Fan Leeat Keren Matthias Mann Lab @DanielaQuail